Latest filings (excl ownership)
424B3
Prospectus supplement
15 May 24
424B3
Prospectus supplement
15 May 24
10-Q
2024 Q1
Quarterly report
15 May 24
POS EX
Additional exhibits for listing
16 Apr 24
424B3
Prospectus supplement
16 Apr 24
424B3
Prospectus supplement
16 Apr 24
10-K
2023 FY
Annual report
16 Apr 24
S-8
Registration of securities for employees
12 Apr 24
8-K
Chromocell Issues Letter to Stockholders from Chief Executive Officer
9 Apr 24
NT 10-K
Notice of late annual filing
1 Apr 24
8-K
Chromocell Announces Formal Launch of Eye Pain Treatment Program and Hiring of Dr. Simon Chandler
21 Mar 24
8-K
Chromocell Names Frank Knuettel as Chief Executive Officer, Removing Interim Status Held Since July 2023
18 Mar 24
8-K
Regulation FD Disclosure
13 Mar 24
8-K
Chromocell Therapeutics Announces Pricing of Upsized $6.6 Initial Public Offering
22 Feb 24
424B4
Prospectus supplement with pricing info
20 Feb 24
424B4
Prospectus supplement with pricing info
20 Feb 24
SEC STAFF
SEC staff action: Order
20 Feb 24
POS EX
Additional exhibits for listing
15 Feb 24
CERT
Certification of approval for exchange listing
15 Feb 24
8-A12B
Registration of securities on exchange
15 Feb 24
EFFECT
Notice of effectiveness
15 Feb 24
S-1/A
IPO registration (amended)
14 Feb 24
FWP
Free writing prospectus
12 Feb 24
S-1/A
IPO registration (amended)
12 Feb 24
CORRESP
Correspondence with SEC
12 Feb 24
CORRESP
Correspondence with SEC
12 Feb 24
FWP
Free writing prospectus
6 Feb 24
S-1/A
IPO registration (amended)
6 Feb 24
FWP
Free writing prospectus
31 Jan 24
S-1/A
IPO registration (amended)
30 Jan 24
CORRESP
Correspondence with SEC
30 Jan 24
UPLOAD
Letter from SEC
25 Jan 24
SEC STAFF
SEC staff action: Order
23 Jan 24
S-1/A
IPO registration (amended)
16 Jan 24
FWP
Free writing prospectus
7 Nov 23
S-1/A
IPO registration (amended)
7 Nov 23
S-1/A
IPO registration (amended)
25 Oct 23
FWP
Free writing prospectus
16 Oct 23
S-1/A
IPO registration (amended)
13 Oct 23
S-1/A
IPO registration (amended)
1 Sep 23
Latest ownership filings
4/A
Ezra M Friedberg
12 Mar 24
SC 13G
Boswell Prayer Ltd.
4 Mar 24
SC 13G
Benuvia Operations, LLC
1 Mar 24
SC 13G
Aperture Healthcare Ventures Ltd.
1 Mar 24
SC 13G
AME Equities LLC
1 Mar 24
SC 13G
Motif Pharmaceuticals Ltd.
1 Mar 24
SC 13G
3i, LP
1 Mar 24
SC 13D
Friedberg Ezra M
26 Feb 24
4
Knuettel Francis II
23 Feb 24
4
Todd C Davis
23 Feb 24
4
Ezra M Friedberg
23 Feb 24
3
Initial statement of insider ownership
15 Feb 24
3
Initial statement of insider ownership
15 Feb 24
3
Initial statement of insider ownership
15 Feb 24
3
Chia-Lin Simmons
15 Feb 24
3
Initial statement of insider ownership
15 Feb 24
3
Richard Malamut
15 Feb 24
3
Eric Lang
15 Feb 24
3
Knuettel Francis II
15 Feb 24
3
Ezra M Friedberg
15 Feb 24
3
Todd C Davis
15 Feb 24